<DOC>
	<DOCNO>NCT03101527</DOCNO>
	<brief_summary>The purpose study determine omega-3 polyunsaturated fatty acid monotherapy antidepressant effect pregnancy . It also provide pilot data pertain relationship apparent response omega-3 monotherapy plasma cytokine erythrocyte essential fatty acid concentration .</brief_summary>
	<brief_title>Open Trial Determining Antidepressant Effects Omega-3 Supplementation During Pregnancy</brief_title>
	<detailed_description>Pregnancy reduce risk recurrence among woman previously experience depressive illness advent new episode pregnancy raise particular problem . Lingering concern possible teratogenicity medication general leave many woman reluctant continue preexist antidepressant prophylaxis accept new trial conventional antidepressant treatment . There also accumulate evidence SSRIs short- , perhaps longer-term , adverse effect newborn . The antidepressant effect omega-3 polyunsaturated fatty acid ( PUFA ) supplementation may offer particularly appropriate alternative conventional therapy depressive episode occur pregnancy . The nutritional need fetus increase likelihood omega-3 PUFA deficits mother access adequate omega-3 PUFAs fish intake limit due concern mercury level . Because polyunsaturated fatty acid dietary component essential fetal development maternal health , use supplementation carry minimal non-existent side effect burden , woman may likely accept omega-3 supplementation conventional antidepressant manage depressive illness provide sufficient evidence effectiveness . Data support antidepressant potential omega-3 PUFA supplementation derive first numerous case-control study associate depressive illness lower tissue concentration omega-3 PUFAs high ratios omega-6 omega-3 . These finding prompt antidepressant trial omega-3 supplementation augmentation mono-therapy many report describe significant benefit placebo , include one target pregnant woman yield large effect size . A number trial , however , fail show clear antidepressant effect . Meta-analyses highlight inconsistency result find explanation differ sample demographic , baseline depressive severity level , PUFA dosing , trial duration . Other source study outcome difference undoubtedly exist clear possibility study positive result involve subject likely truly benefit omega-3 supplementation . The characteristic individual entirely unknown . Though valid predictor antidepressant response omega-3 PUFA supplementation would provide powerful tool personalize treatment study seek identify . One feature might characterize individual likely respond omega-3 PUFA supplementation , course , presence relatively low tissue concentration omega-3 PUFAs and/or high ratio omega-6 omega-3 concentration . The likelihood omega-3 PUFA supplementation exerts antidepressant effect via modulation inflammatory cascade , extensive evidence high level pro-inflammatory marker characterize individual depressive disorder , indicate measure may help select likely benefit treatment omega-3 PUFAs . The identification response predictor specific antidepressant strategy would value selection acute treatment individual active depression could also use choose preventative strategy individual currently depress high risk recent history depressive episode . Prophylaxis depressive illness individual would special importance pregnancy . The adverse effect depressive illness maternal newborn well-being widely appreciate woman develop depressive disorder pregnancy may , variety reason , fail report symptom health care provider , , treatment response may delay even absent one trial .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>1 . Women uncomplicated pregnancy within 1st 2nd trimester pregnancy 2 . Score 10 great nine item Patient Health Questionnaire ( PHQ9 ) depression 1. antidepressant use precede month 2. use previous 4 week psychotropic medication hypnotic benzodiazepine diazepam doseequivalents great equal 2mg/day insomnia 3 . Fish allergy 4. initiation regularly schedule course psychotherapy within previous 2 month</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>omega-3 polyunsaturated fatty acid</keyword>
	<keyword>PUFA</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>eicosapentaenoic acid ( EPA ) supplementation</keyword>
</DOC>